NPNeelam Pushker

Neelam Pushker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Neelam Pushker has a total of 104 co-authors. Here are the top co-authors by number of shared publications:

  • Seema Kashyap

    Ocular Pathology Services, (Dr. Rajendra Prasad Centre for Ophthalmic Sciences), AIIMS, New Delhi, India

    9 shared publications
  • Mandeep S. Bajaj

    Department of Ophthalmology Dr.Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences New Delhi India

    7 shared publications
  • Seema Kashyap

    Ocular Pathology, All India Institute of Medical Sciences, New Delhi, India

    6 shared publications
  • Seema Sen

    Ocular Pathology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

    6 shared publications
  • Rachna Meel

    Oculoplasty and Oncology Services, All India Institute of Medical Sciences, New Delhi, India

    5 shared publications
  • Sahil Agrawal

    Oculoplasty and Oncology Services, All India Institute of Medical Sciences, New Delhi, India

    5 shared publications

Latest Publications

  • Open Access

    Double-bridge novel modification of Cutler–Beard flap for the reconstruction of full-thickness eyelid deformity

    by Neelam Pushker, Sahil Agrawal, Hage Angku, Himani Thakur, Rishav Raj, Rachna Meel, Mandeep S Bajaj

    Introduction: Eyelid deformities can come from birth defects or other causes, and they often need full thickness reconstruction. The Cutler–Beard and Hughes techniques are still the best methods for repairing upper eyelid colobomas. However, there are not many choices available when the eyelid margin is still intact. Here, we report the clinical outcomes of a novel modification of the Cutler–Beard flap surgery in eyelid deformity for these difficult cases. Methods: Design: Retrospective study. Setting: Tertiary care hospital. Study Population: All patients who presented with significantly deficient full-thickness eyelid tissue and severe exposure keratopathy due to lagophthalmos in the last 6 months were studied. Intervention: Patients underwent double-bridge novel modification of the original Cutler–Beard surgery. Main Outcome Measures: The flap survival, correction of eyelid deformity, lagophthalmos, symptomatic improvement, and patient satisfaction were assessed retrospectively. The patients were also followed up for postoperative complications such as lid contour, margin abnormalities, residual lagophthalmos, lymphedema, and donor site complications. Results: Postoperatively, there was satisfactory coverage of the ocular surface in all patients. None of the patients had complications such as flap/bridge necrosis, infection, or excessive secondary contraction of the flap. Chronic lymphedema was observed in one patient due to severe periorbital fibrosis. Conclusion: The Cutler–Beard technique remains a cornerstone in the field of eyelid reconstruction due to its versatility and effectiveness in managing large full-thickness defects of the upper eyelid. The described novel modification adds a new indication to the armamentarium of the modified Cutler–Beard procedures for eyelid reconstruction.

  • Open Access

    Lagophthalmos in Hansen’s disease – Though usual, but something unusual!

    by Neelam Pushker, Shivayan Srivastava, Himani Thakur, Sahil Agrawal, Seema Kashyap

  • Open Access

    Transconjunctival correction of involutional entropion: A video demonstration

    by Neelam Pushker, B. Mounica, Sahil Agrawal

    Background: Involution or aging is the most common cause of lower eyelid entropion (in-turning of eyelid margin) in the elderly population. Various pathomechanisms have been postulated for its occurrence. Aging leads to laxity of tissues and loss of muscle tone. Disinsertion/dehiscence of inferior retractors is considered as the major reason along with the loss of orbicularis muscle tone with or without over-riding of pre-septal fibers onto pretarsal fibers, and laxity of overall eyelid and/canthal tendons. The examination should focus on testing the above-mentioned predisposing factors. The clinical tests are as below. 1. Distraction/pinch test—This test is conducted to assess the overall eyelid laxity. The patient is asked to look in the primary gaze and the lower eyelid is pulled away from the globe. The distance between the pulled eyelid and the globe is measured in millimeters. The laxity is considered significant if the value is more than 6 to 8 mm, which varies according to the age of the patient. 2. Snapback test—This test is conducted to assess the tone of the orbicularis muscle. After doing the distraction test, leave the eyelid and check for its position in relation to the globe. If it snaps back immediately or follows a blink, then it is normal for an old patient. If on leaving the eyelid, it does not come in contact with the globe after blinking repeatedly, then the loss of tone is significant. 3. Medial canthal laxity—Pull the eyelid laterally and observe the shift of the puncta. Laxity is significant if the shift of puncta is 4 mm. 4. Lateral canthal laxity—Pull the eyelid medially and observe the shift of the lateral canthus. Laxity is significant if the shift of the lateral canthus is 4 mm. 5. Eyelid sagging/sclera show—The presence of the sclera due to eyelid sagging is suggestive of significant horizontal lid laxity. 6. Inferior retractor weakness—Inferior retractor weakness occurs because of its dehiscence or disinsertion. The presence of the following signs is suggestive of weakness, that is, higher eyelid resting in primary gaze, eyelid fails to retract on down gaze (normal excursion of the lower eyelid is 3–4 mm), increase in the depth of inferior fornix, and presence of white infratarsal band of retractors separated from the lower tarsal border by a pinkish orbicularis band. Surgical management of involutional entropion includes tackling the vertical component (inferior retractors reinsertion/plication or eyelid margin rotation surgery) with or without the horizontal component. Horizontal tightening (lateral tarsal strip procedure or full-thickness pentagon excision) is indicated in the presence of significant laxity of the overall eyelid and/or canthal laxity. Tackling both vertical and horizontal components gives the best long-term outcome. Purpose: To highlight important surgical steps of transconjunctival correction of left eye involutional entropion in a 70-year-old patient. Synopsis: The video 1 shows the correction of involution entropion by horizontal tightening (lateral tarsal strip procedure) and vertical tightening (advancement and reattachment of inferior retractors on the anterior surface of the tarsus) by conjunctival approach. The limitations of the procedure are mainly that it needs surgical expertise and excessive skin excision if needed cannot be conducted. In our experience, skin excision is not needed in unilateral cases to avoid asymmetry. The suture removal especially at the eyelid margin should be removed at 2–3 weeks to provide a strong attachment of inferior retractors with the tarsal surface. Highlights: Steps of transconjunctival correction of involutional entropion. Video Link: https://youtu.be/JVLi0PngKm4

  • Open Access

    Clinicopathological presentations of eyelid malignancy in COVID era versus pre-COVID era

    by B Mounica, Neelam Pushker, Seema Kashyap, Seema Sen, Sahil Agrawal, Rachna Meel, Mandeep S Bajaj, Sameer Bakhshi

    Purpose: The coronavirus disease 2019 (COVID-19) pandemic led to overall interrupted medical care, resulting in disease progression and morbidity. The study aimed to evaluate clinicopathological presentations and severity of eyelid malignancy during the COVID era, comparing the results with patients presented during pre-COVID era and evaluating the reasons for delayed presentation in patients with advanced eyelid malignancy in the COVID-era. Methods: This was a comparative, ambispective observational study. Data regarding demographic, clinical, histopathology, and treatment modalities of confirmed cases of eyelid malignancy admitted during the period from March 2020 to September 2022 (defined as COVID era group) were collected and compared with retrospectively collected data from March 2017 to March 2020 (defined as pre-COVID era group). COVID era patients were further categorized as localized and advanced disease. Patients with advanced eyelid malignancy during COVID era were further subjected to a questionnaire to evaluate the reasons for delayed presentation. Results: In total, 115 patients of eyelid malignancy were studied [COVID era group 40 (35%) and pre-COVID era group 75 (65%)]. A statistically significant increase in the duration of disease ( P = 0.0001) and advanced tumor T-stage ( P = 0.03) was noticed in the COVID era group. Demographic, histopathology, and ocular morbidity details were similar in both groups. The common reasons that led to delay in presentation and treatment in advanced T-stage patients during the COVID era were fear of acquiring COVID, lockdown, and lack of medical facilities. Conclusion: During the COVID-19 pandemic, both hospital- and patient-related factors contributed to delay in presentation, leading to advanced-stage disease indicating need of triaging of eyelid malignancy in the event of such pandemics in future.

  • The clinical outcomes of minor salivary gland transplantation for severe dry eye disease secondary to chronic Stevens-Johnson syndrome

    by Namrata Sharma, Vishal Kumar, Aafreen Bari, Renu Venugopal, Shivam Sharma, Tushar Agarwal, Tanuj Dada, Neelam Pushker


  • Open Access

    980 Prognostic significance of M1/M2 tumor-associated macrophages with pigmentation in uveal melanoma

    by Jayanti Jha, Lata Singh, Mithalesh Singh, Rachna Meel, Neelam Pushker, Neiwete Lomi, Aanchal Kakkar, Seema Sen, Seema Kashyap

    Background Tumor-Associated Macrophages (TAMs) are associated with an unfavorable outcome in uveal melanoma (UM). Literature showed the correlation between UM with monosomy 3 and an inflammatory phenotype including the presence of TAMs.1 TAMs in UM with monosomy 3 are predominantly pro-angiogenic M2 polarized macrophages which are characterized by CD163. They promote tumor progression and produce cytokines IL 10 in high amounts. Whereas M1 which is characterized by CD68 is generally considered a potent effector cell that kills microorganisms and tumor cells. They produce pro-inflammatory cytokines IL12 in high amounts.2 Studies showed that there was less melanin secretion in the presence of M1 macrophages but increased in the presence of M2 macrophages.3 Additionally, high melanin content could lead to high metastatic potential in UM.4 TRP1 (Tyrosine Related Protein 1) regulates eumelanin synthesis in the Asian population. The oncogenic potential of TAMs in association with pigmentation has not been investigated in UM in the Asian population. Therefore, our study aimed to detect the prognostic significance of TAMs and TYRP1 expression levels in UM patients. Methods Fluorescence In Situ Hybridization (FISH) to detect monosomy 3 was done on 40 UM tissue samples. Immunohistochemistry (IHC) of CD68, CD163 & TRP1 was performed on all UM tissue samples. mRNA expression level of TRP1 was measured by qRT-PCR in all fresh UM cases. ELISA was performed to quantify the expression of IL-10 and IL-12 in UM patients’ serum samples. Cox proportional hazard model and log-rank test were used to determine the prognostic outcome of these markers. Results Infiltrating macrophages in UM cases were predominantly of M2 phenotype. The density of CD163 cells was significantly increased in UM with monosomy 3 and high TRP1 expression compared to disomy 3 and loss of TRP1. Expression of CD163 and TRP1 was correlated with high pigmentation and BAP1 loss. Moreover, UM cases showed high IL10 concentration in comparison to the normal choroid. No significant changes in IL-12 concentration were observed. High expression of TRP1 protein showed reduced disease-free survival (pConclusions Our study showed that high pigmentation might affect the tumor microenvironment in UM by increasing the densities of M2 macrophages leading to tumor progression. This might have a role in the absence of effective antitumor immune responses in UM patients. Our study could provide the development of new therapeutic options that can overcome the immunosuppressive effects. Acknowledgements Jayanti Jha is thankful to the Indian Council of Medical Research for providing SRF (Senior Research Fellowship). References Herwig MC, Bergstorm C, Wells JR, et al. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Eye Res. 2013;107:52–58. Wang YC, He F, Feng F, et al. Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses. Cancer Res. 2010;70. Han H, Kim Y, Mo H, et al. Preferential stimulation of melanocytes by M2 macrophages to produce melanin through vascular endothelial growth factor. Scientific Reports. 2022;12:6416. Kashyap S, Singh MK, Jha J, et al. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma. Human Cell. 2020. https://doi.org/10.1007/s13577–020-00397–9. Ethics Approval Ethical approval was obtained from the Institute’s Ethical Committee, All India Institute of Medical Sciences. (approval ID# IECPG-501/17.07.2019) Consent Written informed consent was obtained from all patients before participation in this study.

  • Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target

    by Sheetal Chauhan, Seema Sen, Khushboo Irshad, Seema Kashyap, Neelam Pushker, Rachna Meel, Mehar Chand Sharma

    Receptor tyrosine kinases (RTKs) serve as molecular targets for the development of novel personalized therapies in many malignancies. In the present study, expression pattern of receptor tyrosine kinases and its clinical significance in orbital RMS has been explored. Eighteen patients with histopathologically confirmed orbital RMS formed part of this study. Comprehensive q-PCR gene expression profiles of 19 RTKs were generated in the cases and controls. The patients were followed up for 59.53 ± 20.93 years. Clustering and statistical analysis tools were applied to identify the significant combination of RTKs associated with orbital rhabdomyosarcoma patients. mRNA overexpression of RTKs which included MET, AXL, EGFR was seen in 60–80% of cases; EGFR3, IGFR2, FGFR1, RET, PDGFR1, VEGFR2, PDGFR2 in 30–60% of cases; and EGFR4, FGFR3,VEGFR3 and ROS,IGFR1, EGFR1, FGFR2, VEGFR1 in 10–30% of cases. Immunoexpression of MET was seen in 89% of cases. A significant association was seen between MET mRNA and its protein expression. In all the cases MET gene expression was associated with worst overall survival (P = 0.03).There was a significant correlation of MET mRNA expression with RET, ROS, AXL, FGFR1, FGFR3, PDGFR1, IGFR1, VEGFR2, and EGFR3 genes. Association between MET gene and collective expression of RTKs was further evaluated by semi-supervised gene cluster analysis and Principal component analysis, which showed well-separated tumor clusters. MET gene overexpression could be a useful biomarker for identifying high risk orbital rhabdomyosarcoma patients. Well-separated tumor clusters confirmed the association between MET gene and collective expression of RTK genes. Therefore, the therapeutic potential of multi-kinase inhibitors targeting MET and the 9 other significant RTKs needs to be explored.


  • Open Access

    Clinico-demographic profile of orbital exenteration in a tertiary eye care centre – a 20 years’ experience

    by Rachna Meel, Neelam Pushker, Seema Kashyap, Shweta Chaurasia, Aishwarya Rathod, Mandeep Bajaj, Seema Sen, Sahil Agrawal

    Background This study aimed to determine the clinical indications for orbital exenteration, demographic profile of these patients and clinicopathological correlations in current times, and to compare these results with previous published data. Methods A retrospective analysis was conducted of exenterations performed at a tertiary eye care centre over a period of 20 years(January 2001 to June 2020). Patient records were reviewed to obtain demographic data, presenting symptoms and their duration, laterality, and clinical and histopathological diagnosis. Results A total of 352 cases(males: females, 222:130) were identified who underwent exenteration. Patients ranged in age from 11months to 87 years(mean: 43.86 years, median: 50 years). The most common indication for exenteration was found to be eyelid malignancy in 54.36% followed by retinoblastoma in 18.75% and primary orbital tumors in 14.49%. Squamous cell carcinoma(SCC)(60.26%) was most common histologic subtype of eyelid malignancy requiring exenteration, followed by sebaceous gland carcinoma(25.64%), and basal cell carcinoma(12.82%). The most common primary orbital tumors requiring exenteration were adenocystic carcinoma of lacrimal gland in adults and rhabdomyosarcoma in paediatric age group. Benign conditions requiring exenteration included fulminant fungal orbital infections and lymphangioma amongst others. Conclusion The number of exenterations performed have significantly increased in terms of absolute numbers. However, the ratio of exenteration to other tumor related surgeries, mainly excision biopsy, has reduced as compared to that reported from previous study. The most common indication in our study remains eyelid malignancy followed by intraocular malignancy. However, SCC has emerged as the most common tumor histologic subtype requiring exenterations.